Undergoing treatment with radium

Malignant neoplasm of bone and articular cartilage - Undergoing treatment with radium Factor

Last reviewed for CCPS 30 September 2002.

Preliminary questions [13166]

32086 there is some evidence that treatment with radium-224, radium-226 or radium-228 may be a factor in the development of the condition under consideration.

32087 the veteran has undergone treatment with radium-224, radium-226 or radium-228 at some time.

32088 the veteran underwent the treatment with radium-224, radium-226 or radium-228 for treatment of an illness or injury which is identifiable.

32116

the veteran underwent the treatment with radium-224, radium-226 or radium-228 for treatment of the identified illness or injury before the clinical onset of the condition under consideration.

32090 — the veteran has established the causal connection between the treatment with radium-224, radium-226 or radium-228 and VEA service for the clinical onset of the condition under consideration.

32091 — the veteran has established the causal connection between the treatment with radium-224, radium-226 or radium-228 and operational service for the clinical onset of the condition under consideration.

or

32092 — the veteran has established the causal connection between the treatment with radium-224, radium-226 or radium-228 and eligible service for the clinical onset of the condition under consideration.

Clinical onset and operational service [32091]

32163 — the identified illness or injury for which the treatment with radium-224, radium-226 or radium-228 was undergone is causally related to operational service.

Clinical onset and eligible service [32092]

32164 — the identified illness or injury for which the treatment with radium-224, radium-226 or radium-228 was undergone is causally related to eligible service.